Literature DB >> 11908684

Squamous cell head and neck cancer: evidence of angiogenic regeneration during radiotherapy.

M I Koukourakis1, A Giatromanolaki, E Sivridis, K Simopoulos, G Pissakas, K C Gatter, A L Harris.   

Abstract

BACKGROUND AND
PURPOSE: Intra-tumoural neoangiogenesis is an essential process for tumour progression. Although intensification of angiogenic pathways during cytotoxic therapy has been reported by a few experimental studies, the role of angiogenesis in response to radiotherapy is unclear. We recently reported an adverse effect of intense angiogenesis in the radiotherapy outcome of squamous cell head and neck cancer (SCHNC). In the present study we investigated the radiotherapy-induced changes in the microvessel density (MVD) and in the expression of the angiogenic factor thymidine phosphorylase (TP) in SCHNC. PATIENTS AND METHODS: Twenty-four patients with SCHNC underwent a biopsy of the primary lesion immediately before and after delivery of 20Gy of conventionally fractionated radiotherapy. The MVD and the expression of TP was assessed with immunohistochemistry.
RESULTS: The irradiated samples were composed of cancer cell islets or bands, immersed within avascular degenerated tissue. In tumours that did not reach complete response after the end of radiotherapy, these viable cancer tissue areas had a significantly higher MVD (p=0.006) and increased percentage of cancer cells with nuclear TP expression (p=0.0004) than the MVD and the TP expression noted in specimens before radiotherapy. TP expression in these islets was directly related to the MVD (p=0.004, r=0.56).
CONCLUSION: The present study supports the idea that intensified angiogenic growth (angiogenic regeneration) during radiotherapy is associated with failure of radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11908684

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation.

Authors:  Ruslan Hlushchuk; Oliver Riesterer; Oliver Baum; Jeanette Wood; Guenther Gruber; Martin Pruschy; Valentin Djonov
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

2.  Angiogenic regeneration defines loco-regional recurrence following pre-operative radio-chemotherapy for rectal cancer: a pilot study.

Authors:  Michael I Koukourakis; Ioannis M Koukourakis; Stella Arelaki; Maria Kouroupi; Spyros Domoxoudis; Alexandra Giatromanolaki
Journal:  Mol Biol Rep       Date:  2019-02-05       Impact factor: 2.316

3.  The inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms.

Authors:  Huita Wu; Jie Deng; Shiying Yu; Xin Wang; Yuan Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

4.  Updating advances on recombinant human endostatin combined with radiotherapy for non-small cell lung cancer with brain metastasis.

Authors:  Xiao-Dong Jiang; Yun Qiao
Journal:  Transl Lung Cancer Res       Date:  2012-03

5.  Radiochemotherapy-induced changes of tumour vascularity and blood supply estimated by dynamic contrast-enhanced CT and fractal analysis in malignant head and neck tumours.

Authors:  A Abramyuk; V Hietschold; S Appold; R von Kummer; N Abolmaali
Journal:  Br J Radiol       Date:  2015-01       Impact factor: 3.039

6.  Effect of thalidomide and arsenic trioxide on the release of tumor necrosis factor-α and vascular endothelial growth factor from the KG-1a human acute myelogenous leukemia cell line.

Authors:  Erian H Girgis; John P Mahoney; Rafaat H Khalil; Magdi R Soliman
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

7.  Correlation between tumor growth delay and expression of cancer and host VEGF, VEGFR2, and osteopontin in response to radiotherapy.

Authors:  Timothy D Solberg; Jessica Nearman; John Mullins; Sicong Li; Janina Baranowska-Kortylewicz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-01       Impact factor: 7.038

8.  Radiotherapy in combination with vascular-targeted therapies.

Authors:  Eva Ciric; Gregor Sersa
Journal:  Radiol Oncol       Date:  2010-05-24       Impact factor: 2.991

9.  Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1.

Authors:  S M Sagar; D Yance; R K Wong
Journal:  Curr Oncol       Date:  2006-02       Impact factor: 3.677

Review 10.  Hypoxia in head and neck cancer in theory and practice: a PET-based imaging approach.

Authors:  Loredana G Marcu; Wendy M Harriss-Phillips; Sanda M Filip
Journal:  Comput Math Methods Med       Date:  2014-08-21       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.